Successful CP Kelco Integration
Integration of CP Kelco completed smoothly without customer disruption; cross-selling pipeline more than doubled in H2 to over $100m and ~10% of the targeted $70m revenue synergies (10% of CP Kelco revenue) have been delivered to date.
Statutory Revenue and EBITDA Growth (including acquisition)
On a statutory basis (including CP Kelco), revenue was 16% higher and adjusted EBITDA was 13% higher for the year ended 31 March 2026.
Cost Synergies and Productivity Delivered Ahead of Plan
Met annualized run-rate cost synergies target of at least $50m one year early (delivering $24m in the year); delivered $53m of productivity savings in the year and $144m over the last 3 years; 5-year productivity target increased from $150m to $200m by end-FY2028.
Robust Balance Sheet and Liquidity
Net debt £939m with leverage at 2.3x net debt/EBITDA (target range 1.0–2.5x); weighted average cost of debt ~4% and maturity 4.7 years; nearly £1bn of available liquidity including a committed $800m revolving credit facility extended to 2031.
Growing New Business and Solutions Momentum
New business pipeline value up 15%; revenue from new products increased 9% on a like-for-like basis; solutions comprised 35% of new business wins; concrete customer solution wins reported (e.g., fiber fortification delivering +6g fiber per serving and multiple product launches).
Resilient Margin Profile
Adjusted EBITDA margin reported at 20.7% and broadly flat on a constant currency basis, described as attractive versus specialty ingredient peers.
Positive Outlook for FY2027
Management expects modest revenue growth in FY2027 underpinned by volume growth weighted to H2 and broadly flat EBITDA (before the ~$20m impact from rescheduling the bio-gums consolidation); early signs of top-line momentum observed in April/May.